Contract facts
UnrestrictedNo full NAICS 541714 intel page yet. Browse NAICS intelligence
EXECUTION OF THE CLINICAL METHOD COMPARISON STUDY AND REGULATORY SUBMISSION REQUIRED TO BE GRANTED CLIA-WAIVER FROM THE FDA FOR FEBRIDX RESPONSE TO BAA-23-100-SOL-00004 is a federal Unrestricted award for Barda - Aspr / Daappo / Barda Dcma held by Lumos Diagnostics, Inc. Estimated value $9.2M ($9.2M obligated). Current period of performance ends Jun 30, 2027. Last award drew 1 bidder. Place of performance: CARLSBAD CA. Related solicitation BAA-23-100-SOL-00004.
EXECUTION OF THE CLINICAL METHOD COMPARISON STUDY AND REGULATORY SUBMISSION REQUIRED TO BE GRANTED CLIA-WAIVER FROM THE FDA FOR FEBRIDX RESPONSE TO BAA-23-100-SOL-00004
Recompete timing
PublicCurrent PoP ends Jun 30, 2027 (276 days remaining). Agencies typically plan 12–18 months ahead — at 9.1 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75A50124C00051? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordLumos Diagnostics, Inc — $9.2M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50124C00051?
75A50124C00051 (Execution of the clinical METHOD comparison) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $9.2M, currently held by Lumos Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50124C00051?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50124C00051 to Lumos Diagnostics, Inc (potential $9.2M).
Who is the incumbent on 75A50124C00051?
Lumos Diagnostics, Inc is the incumbent with $9.2M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2027.
When does Lumos Diagnostics, Inc’s 75A50124C00051 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75A50124C00051? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.